Topic: Depakote

Abbott Laboratories (ABT) Q3 2007 Earnings Call October 17, 2007 9:00 am ET. SG&A expense included the impact of the Kos acquisition, as well as new and ongoing promotionalinitiatives, including new indications for HUMIRA and the continuinginternational launch of XIENCE.. Finally as ...